Integrated Site Operations
OncoBay acknowledges the importance of quality site engagement. Our foundation is built on our vision to transform IO research through innovation, collaboration, and partnership to positively impact the lives of people with cancer. Success requires an innovative approach yielding a unique level of site access, PI engagement, and unparalleled executional excellence.
OncoBay has gone beyond the expected, beyond the traditional, and beyond the required.
To achieve our vision, access to patients—through their treating physician and within their community—is fundamental. To that end, we have established core relationships that create site and sponsor opportunity.
Oncology Site Network
OncoNet IO
These sites have been vetted specifically for their ability to activate quickly, identify large numbers of patients, and integrate successfully within the OncoBay Clinical technology ecosystem. Working with these sites allows unparalleled transparency and efficiency, and many are also capable of working in JIT models.
Onco CTx
With the support of Moffitt Cancer Center, these sites have been specifically vetted and trained by OncoBay to conduct cell therapy trials. The sites have the capabilities, expertise and resources to execute the complex requirements of CTx studies and enhance access to patients.
OncoNet IO Network Value Proposition
SPONSOR
Enhanced access to patients
Ability to deliver a larger number of studies across fewer sites leading to improve consistency of delivery, increased quality and predictability
Project delivered faster, more efficiently and with higher quality
Improved site selection process ensuring the right site receives the right study
NETWORK SITE
Increased access OncoBay Clinical studies that align with the sites research interest: streamlined feasibility and waived Qualification
Streamlined process related to study start-up activities and study execution
Enhanced risk-based monitoring with eSource technologies, eISF, and virtual visits
Opportunities to shape new clinical trial technologies and methologies
A clear, transparent point of contact across all studies within OncoBay Clinical
Commitment to prioritized and transparent payment
Onco CTx Consortium Value Proposition
Sponsor
Enhance access to patients
Access to sites trained and developed by Moffitt Cancer Center
Ability to deliver a large number of cell therapy studies across fewer sites leading to improved consistency of delivery, increased quality and predictability
Project delivered faster, more efficiently and with higher quality
Consortium Site
All of the benefits of the Network Sites, plus…
Collaboration with other Consortium sites
Commercial REMS-required Training and Knowledge Assessment
Processes and procedures to ensure that appropriate requirements for cell therapies are met
Research site support as needed
Marketing of the Consortium, including for studies separate from OncoBay as a CRO
